4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18548807 | HB-EGF GENE THERAPY FOR DIABETES | MCCORMICK, CATHERINE LYNN | 1638 | Non-Final OA | Sep 01, 2023 |
| 18253651 | LOW-DOSE HEPATOCYTE GROWTH FACTOR GENE THERAPY FOR DIABETES | TSAY, MARSHA M | 1656 | Non-Final OA | May 19, 2023 |
| 17770978 | METHOD FOR PRODUCING MONOVALENT CCAP PRODUCT | REDDIG, PETER J | 1646 | Non-Final OA | Apr 21, 2022 |
| 17430557 | ANTIPRURITIC AGENT USING PAC1 RECEPTOR ANTAGONIST | HAVLIN, ROBERT H | 1626 | Non-Final OA | Jan 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial